BOSTON—(BUSINESS WIRE)—Medical device and technology company Lazurite™ will be one of 50 early and mid-stage device, diagnostic and digital health companies participating in the 2022 MedTech Innovator Showcase at The MedTech Conference, powered by AdvaMed, Oct. 24-26 in Boston. The MedTech Conference is considered the industry’s largest and most important annual event.
MedTech Innovator, the world’s largest accelerator of medical technology companies, selected the 50 companies from more than 1,000 applications for the 2022 cohort of its flagship four-month Accelerator program, which began in June. Lazurite was selected on account of its breakthrough ArthroFree™ Wireless Surgical Camera System.
In 13 showcase sessions at The MedTech Conference organized around industry themes, four to six Accelerator Program CEOs/Founders will present their technologies and value propositions. Five finalists will go on to compete during the MedTech Innovator Finals, with a live audience vote and the opportunity to win $500,000 in prizes and the title of MedTech Innovator 2022.
In addition to the MedTech Innovator Showcase, Lazurite will also be among a select group of early-stage companies exhibiting in the Innovation Pavilion at The MedTech Conference. Attendees will be able to demo the ArthroFree System and meet with Lazurite representatives at Booth 921.
“We are proud to be part of the MedTech Innovator Accelerator Program,” Lazurite CEO and Cofounder Eugene Malinskiy said. “It has enabled us to meet a host of key opinion leaders, investors and innovators, and we’re definitely excited by the prospect of vying for the $500,000 in prize money at the MedTech Conference as we move closer to delivery of the first ArthroFree operating room kits.”
The ArthroFree™ Wireless Surgical Camera System is the first wireless surgical camera to receive 510(k) clearance from the Food and Drug Administration for arthroscopy and general endoscopy. The first in-patient use of ArthroFree took place at NYU Langone Orthopedic Center in mid-September and launched the commercialization of the product.
By eliminating conventional camera cables that tether surgeons to the surgical tower and hinder their movement, the ArthroFree System is expected to increase OR efficiency and lower customer costs. Additionally, with its solid state, low heat, high efficiency Meridiem™ light technology, the system promises to eliminate camera related patient burns and OR fires. The modular system is designed to be drop-in compatible with existing patient data consoles, surgical displays and endoscopes found in minimally invasive operating rooms.
About the MedTech Conference
The MedTech Conference, powered by AdvaMed, brings together the top executives and innovators from across the world and the industry to explore critical topics, share visions for the future—and build them, together. Regarded as a homecoming for the global medtech community, this event serves as the incubator for the ideas, partnerships and innovations that lead to a healthier world. For more information, see: The MedTech Conference.
About MedTech Innovator
MedTech Innovator is the industry’s nonprofit global competition and accelerator for medical device, digital health and diagnostic companies, with a mission to improve the lives of patients by accelerating the growth of companies that are transforming the health care system. For more information, see MedTech Innovator.
Lazurite is a medical device and technology company. Its ArthroFree™ System—the wireless camera for arthroscopy and general endoscopy—is designed for surgeons seeking surgical tools for greater agility in the OR. ArthroFree is drop-in compatible with current OR technologies, and it promises to eliminate patient burns, OR fires, and staff trips and falls. With the ArthroFree System, Lazurite ushers in the wireless era of surgical visualization. Lazurite’s intellectual property portfolio also includes the low-heat Meridiem light technology and products in development. The pre-revenue company is located in Cleveland, OH (est. 2015), and to date has raised ~$25M from institutional investors, family offices, and more than 75 physician champions. The mission: solve impossible problems to improve people’s lives. The 10-year vision: better outcomes for one million patients—and thousands of clinicians, too. For more information, see: https://lazurite.co.
Lazurite™, ArthroFree™, and Meridiem™ are trademarks of Lazurite LLC.